根據最新的財務報表(Form-10K),Envoy Medical Inc 的總資產為 $11,淨損失為 $-27
COCH 的關鍵財務比率是什麼?
Envoy Medical Inc 的流動比率為 0.36,淨利潤率為 0,每股銷售為 $0。
Envoy Medical Inc 的收入按細分市場或地理位置如何劃分?
Envoy Medical Inc 最大收入來源為 Hearing Devices,在最近的收益報告中收入為 225,000。就地區而言,United States 是 Envoy Medical Inc 的主要市場,收入為 225,000。
Envoy Medical Inc 是否盈利?
無,根據最新的財務報表,Envoy Medical Inc 的淨損失為 $-27
Envoy Medical Inc 有負債嗎?
是的,Envoy Medical Inc 的負債為 30
Envoy Medical Inc 的流通股有多少?
Envoy Medical Inc 的總流通股為 21.32
關鍵數據
前收市價
$0.705
開盤價
$0.7168
當日範圍
$0.6755 - $0.76
52週區間
$0.363 - $1.91
交易量
122.9K
平均成交量
780.8K
股息收益率
4.87%
每股盈餘 (TTM)
-1.80
市值
$21.6M
什麼是 COCH?
Envoy Medical, Inc. is a hearing health company, which engages in providing medical technologies across the hearing loss spectrum. The company is headquartered in White Bear Lake, Minnesota and currently employs 42 full-time employees. The company went IPO on 2021-03-02. The firm is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.